{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:16:29Z","timestamp":1791296189665,"version":"4.1.0"},"reference-count":266,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001742","name":"United States-Israel Binational Science Foundation","doi-asserted-by":"crossref","award":["BSF 2007188"],"award-info":[{"award-number":["BSF 2007188"]}],"id":[{"id":"10.13039\/501100001742","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.neuropharm.2011.04.019","type":"journal-article","created":{"date-parts":[[2011,6,27]],"date-time":"2011-06-27T11:20:48Z","timestamp":1309173648000},"page":"1273-1289","source":"Crossref","is-referenced-by-count":100,"title":["Tracing the development of psychosis and its prevention: What can be learned from animal models"],"prefix":"10.1016","volume":"62","author":[{"given":"Yael","family":"Piontkewitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Arad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2011.04.019_bib1","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1176\/ajp.155.6.761","article-title":"Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort","volume":"155","author":"Abi-Dargham","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib2","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1152\/physrev.00055.2003","article-title":"Adult neurogenesis: from precursors to network and physiology","volume":"85","author":"Abrous","year":"2005","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib3","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1192\/bjp.163.4.522","article-title":"Epidemiological evidence that maternal influenza contributes to the aetiology of schizophrenia. An analysis of Scottish, English, and Danish data","volume":"163","author":"Adams","year":"1993","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/PL00005038","article-title":"Developmental differences in dopamine synthesis inhibition by (+\/-)-7-OH-DPAT","volume":"356","author":"Andersen","year":"1997","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/1098-2396(200008)37:2<167::AID-SYN11>3.0.CO;2-B","article-title":"Dopamine receptor pruning in prefrontal cortex during the periadolescent period in rats","volume":"37","author":"Andersen","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib6","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/npp.2010.28","article-title":"Contrasting effects of increased and decreased dopamine transmission on latent inhibition in ovariectomized rats and their modulation by 17beta-estradiol: an animal model of menopausal psychosis?","volume":"35","author":"Arad","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib7","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1038\/npp.2010.89","article-title":"Sex-dependent antipsychotic capacity of 17beta-estradiol in the latent inhibition model: a typical antipsychotic drug in both sexes, atypical antipsychotic drug in males","volume":"35","author":"Arad","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/schbul\/sbp153","article-title":"Cognition in mouse models of schizophrenia susceptibility genes","volume":"36","author":"Arguello","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1017\/S095457949900214X","article-title":"Neurodevelopmental abnormalities in schizophrenia: insights from neuropathology","volume":"11","author":"Arnold","year":"1999","journal-title":"Dev. Psychopathol."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib10","article-title":"Neonatal behavioral changes in rats with gestational exposure to lipopolysaccharide: a prenatal infection model for developmental neuropsychiatric disorders","author":"Baharnoori","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.schres.2008.10.003","article-title":"Prenatal immune challenge induces developmental changes in the morphology of pyramidal neurons of the prefrontal cortex and hippocampus in rats","volume":"107","author":"Baharnoori","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/jnr.10440","article-title":"Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs","volume":"71","author":"Bai","year":"2003","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1469-7610.1977.tb00425.x","article-title":"A\u00a0review of stimulant drug research with hyperactive children","volume":"18","author":"Barkley","year":"1977","journal-title":"J.\u00a0Child Psychol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib14","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1126\/science.7079742","article-title":"Neurons in the rat dentate gyrus granular layer substantially increase during juvenile and adult life","volume":"216","author":"Bayer","year":"1982","journal-title":"Science"},{"issue":"Suppl. 4","key":"10.1016\/j.neuropharm.2011.04.019_bib15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/PL00014184","article-title":"Developmental malformations in cerebral structures of schizophrenic patients","volume":"249","author":"Beckmann","year":"1999","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib16","doi-asserted-by":"crossref","first-page":"9797","DOI":"10.1523\/JNEUROSCI.2200-08.2008","article-title":"Critical role of the prefrontal cortex in the regulation of hippocampus-accumbens information flow","volume":"28","author":"Belujon","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib17","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.tins.2008.09.002","article-title":"Neuro-archaeology: pre-symptomatic architecture and signature of neurological disorders","volume":"31","author":"Ben-Ari","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib18","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/schbul\/15.4.585","article-title":"Myelination of cortical-hippocampal relays during late adolescence","volume":"15","author":"Benes","year":"1989","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib19","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archpsyc.1994.03950060041004","article-title":"Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood","volume":"51","author":"Benes","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib20","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/schbul\/18.3.437","article-title":"Intellectual deficits in first-episode schizophrenia: evidence for progressive deterioration","volume":"18","author":"Bilder","year":"1992","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib21","series-title":"Dementia Praecox or the Group of Schizophrenias","author":"Bleuler","year":"1911"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib22","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.bbi.2010.03.005","article-title":"Effects of prenatal infection on brain development and behavior: a review of findings from animal models","volume":"24","author":"Boksa","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib23","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.schres.2008.08.007","article-title":"Reductions in frontal, temporal and parietal volume associated with the onset of psychosis","volume":"106","author":"Borgwardt","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib24","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1073\/pnas.94.6.2569","article-title":"Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method","volume":"94","author":"Breier","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib25","series-title":"Olfaction and the Brain","first-page":"103","article-title":"Olfactory processing and brain maturation","author":"Brewer","year":"2006"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib26","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/archpsyc.61.8.774","article-title":"Serologic evidence of prenatal influenza in the etiology of schizophrenia","volume":"61","author":"Brown","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib28","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1176\/appi.ajp.161.5.889","article-title":"Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring","volume":"161","author":"Brown","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1176\/appi.ajp.2009.09030361","article-title":"Prenatal infection and schizophrenia: a review of epidemiologic and translational studies","volume":"167","author":"Brown","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/mrdd.10004","article-title":"In utero infection and adult schizophrenia","volume":"8","author":"Brown","year":"2002","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib30","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1176\/appi.ajp.2008.08010089","article-title":"Prenatal exposure to maternal infection and executive dysfunction in adult schizophrenia","volume":"166","author":"Brown","year":"2009","journal-title":"Am. J.\u00a0Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.schres.2005.06.014","article-title":"Clinical and genetic high-risk strategies in understanding vulnerability to psychosis","volume":"79","author":"Cannon","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib32","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/oxfordjournals.schbul.a007037","article-title":"Early and late\u00a0neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions","volume":"29","author":"Cannon","year":"2003","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib33","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/cercor\/6.5.726","article-title":"The human brain age 7\u201311 years: a volumetric analysis based on magnetic resonance images","volume":"6","author":"Caviness","year":"1996","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib34","series-title":"Estimating the Safe Starting Dose in Clinical Trials for Therapeutics in Adult Healthy Volunteers","author":"Center for Drug Evaluation and Research, C. f. B.E. a. R","year":"2002"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/schbul\/sbp073","article-title":"Brain Anatomical abnormalities in high-risk individuals, first-episode, and chronic schizophrenia: an activation likelihood estimation meta-analysis of illness progression","volume":"37","author":"Chan","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib36","article-title":"A\u00a0lifespan MRI evaluation of ventricular enlargement in normal aging mice","author":"Chen","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.euroneuro.2009.09.002","article-title":"Effects of repeated risperidone exposure on serotonin receptor subtypes in developing rats","volume":"20","author":"Choi","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib38","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1148\/radiology.216.3.r00au37672","article-title":"Normal brain development and aging: quantitative analysis at in\u00a0vivo MR imaging in healthy volunteers","volume":"216","author":"Courchesne","year":"2000","journal-title":"Radiology"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib39","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/j.pnpbp.2008.09.020","article-title":"Effect of antipsychotic drugs on brain morphometry. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine","volume":"32","author":"Crespo-Facorro","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib40","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.schres.2009.05.003","article-title":"Effects of prenatal immune activation on hippocampal neurogenesis in the rat","volume":"113","author":"Cui","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib41","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/cercor\/11.6.552","article-title":"Sex differences in brain maturation during childhood and adolescence","volume":"11","author":"De Bellis","year":"2001","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib42","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/schbul\/sbm164","article-title":"The concept of progressive brain change in schizophrenia: implications for understanding schizophrenia","volume":"34","author":"DeLisi","year":"2008","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib43","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/sj.npp.1300710","article-title":"The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys","volume":"30","author":"Dorph-Petersen","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib44","first-page":"137","article-title":"Polyinosinic:polycytidylic acid is a potent activator of endothelial cells","volume":"145","author":"Doukas","year":"1994","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib45","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.327.5967.770-b","article-title":"Psychiatry. DSM-V at a glance","volume":"327","author":"DSM-V","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1503\/jpn.090049","article-title":"Hippocampal and caudate volume reductions in antipsychotic-naive first-episode schizophrenia","volume":"35","author":"Ebdrup","year":"2010","journal-title":"J.\u00a0Psychiatry Neurosci."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib47","doi-asserted-by":"crossref","first-page":"11785","DOI":"10.1523\/JNEUROSCI.3798-08.2008","article-title":"Adult neurogenesis, mental health, and mental illness: hope or hype?","volume":"28","author":"Eisch","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib48","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0165-0173(94)00014-G","article-title":"The N-methyl-d-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias","volume":"20","author":"Ellison","year":"1995","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0920-9964(96)00024-2","article-title":"Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity","volume":"21","author":"Farber","year":"1996","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib50","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/schbul\/sbn187","article-title":"The neurodevelopmental hypothesis of schizophrenia, revisited","volume":"35","author":"Fatemi","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib51","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.schres.2007.11.018","article-title":"Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders","volume":"99","author":"Fatemi","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib52","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0022-3956(82)90038-3","article-title":"Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?","volume":"17","author":"Feinberg","year":"1982","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib53","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.eurpsy.2008.03.008","article-title":"Neuroimaging studies of the early stages of psychosis: a critical review","volume":"23","author":"Fusar-Poli","year":"2008","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib54","article-title":"Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis","author":"Fusar-Poli","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib55","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/archgenpsychiatry.2010.77","article-title":"Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study","volume":"67","author":"Fusar-Poli","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib56","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.neubiorev.2006.11.006","article-title":"Neurofunctional correlates of vulnerability to psychosis: a systematic review and meta-analysis","volume":"31","author":"Fusar-Poli","year":"2007","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib57","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.biopsych.2005.02.008","article-title":"Cerebral cortical gray expansion associated with two second-generation antipsychotics","volume":"58","author":"Garver","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib58","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/nrn1256","article-title":"The developmental role of serotonin: news from mouse molecular genetics","volume":"4","author":"Gaspar","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib59","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tips.2008.06.006","article-title":"Serotonin research: contributions to understanding psychoses","volume":"29","author":"Geyer","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib60","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/13158","article-title":"Brain development during childhood and adolescence: a longitudinal MRI study","volume":"2","author":"Giedd","year":"1999","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib61","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0278-5846(99)00017-2","article-title":"Development of the human corpus callosum during childhood and adolescence: a longitudinal MRI study","volume":"23","author":"Giedd","year":"1999","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib62","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0278-5846(97)00158-9","article-title":"Sexual dimorphism of the developing human brain","volume":"21","author":"Giedd","year":"1997","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib63","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0006-3223(99)00072-4","article-title":"Childhood-onset schizophrenia: progressive brain changes during adolescence","volume":"46","author":"Giedd","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib64","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/0165-3806(95)00193-X","article-title":"A\u00a0quantitative MRI study of the corpus callosum in children and adolescents","volume":"91","author":"Giedd","year":"1996","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib65","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/(SICI)1096-9861(19960304)366:2<223::AID-CNE3>3.0.CO;2-7","article-title":"Quantitative MRI of the temporal lobe, amygdala, and hippocampus in normal human development: ages 4\u201318 years","volume":"366","author":"Giedd","year":"1996","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib66","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0920-9964(96)00123-5","article-title":"Exposure to infection and brain development: cytokines in the pathogenesis of schizophrenia","volume":"24","author":"Gilmore","year":"1997","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib67","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0165-5728(03)00095-X","article-title":"Maternal infection regulates BDNF and NGF expression in fetal and neonatal brain and maternal-fetal unit of the rat","volume":"138","author":"Gilmore","year":"2003","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib68","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jneuroim.2004.10.008","article-title":"Maternal poly I: C exposure during pregnancy regulates TNF alpha, BDNF, and NGF expression in neonatal brain and the maternal-fetal unit of the rat","volume":"159","author":"Gilmore","year":"2005","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib69","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/hipo.20193","article-title":"Dynamic mapping of normal human hippocampal development","volume":"16","author":"Gogtay","year":"2006","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib70","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/archpsyc.61.1.17","article-title":"Comparison of progressive cortical gray matter loss in childhood-onset schizophrenia with that in childhood-onset atypical psychoses","volume":"61","author":"Gogtay","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib71","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.neuropharm.2004.12.023","article-title":"Specific neurodevelopmental damage in mice offspring following maternal inflammation during pregnancy","volume":"48","author":"Golan","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib72","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0090-4295(00)00936-5","article-title":"A\u00a0double-blind, placebo-controlled, efficacy and safety study of topical gel formulation of 1% alprostadil (Topiglan) for the in-office treatment of erectile dysfunction","volume":"57","author":"Goldstein","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib73","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0165-0173(99)00049-1","article-title":"Gating of information flow within the limbic system and the pathophysiology of schizophrenia","volume":"31","author":"Grace","year":"2000","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib74","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s12640-010-9154-6","article-title":"Dopamine system dysregulation by the ventral subiculum as the common pathophysiological basis for schizophrenia psychosis, psychostimulant abuse, and stress","volume":"18","author":"Grace","year":"2010","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0074-7742(06)78001-1","article-title":"Neurobiology of dopamine in schizophrenia","volume":"78","author":"Guillin","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib76","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1523\/JNEUROSCI.19-10-04065.1999","article-title":"Sex differences in brain gray and white matter in healthy young adults: correlations with cognitive performance","volume":"19","author":"Gur","year":"1999","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib77","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/schbul\/sbm045","article-title":"Deconstructing psychosis with human brain imaging","volume":"33","author":"Gur","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib78","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1017\/S0033291700005626","article-title":"How does gender influence age at first hospitalization for schizophrenia? A transnational case register study","volume":"19","author":"Hafner","year":"1989","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib79","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.tips.2006.05.005","article-title":"Targeting information-processing deficit in schizophrenia: a novel approach to psychotherapeutic drug discovery","volume":"27","author":"Hajos","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib80","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/sj.npp.1300422","article-title":"Effects of chronic haloperidol and clozapine treatment on neurogenesis in the adult rat hippocampus","volume":"29","author":"Halim","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"Pt 4","key":"10.1016\/j.neuropharm.2011.04.019_bib81","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/brain\/122.4.593","article-title":"The neuropathology of schizophrenia. A critical review of the data and their interpretation","volume":"122","author":"Harrison","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib82","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00213-003-1761-y","article-title":"The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications","volume":"174","author":"Harrison","year":"2004","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib83","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/sj.mp.4001558","article-title":"Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence","volume":"10","author":"Harrison","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib84","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archpsyc.60.6.585","article-title":"Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia","volume":"60","author":"Ho","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib85","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/schbul\/15.3.477","article-title":"Cortical pruning and the development of schizophrenia: a computer model","volume":"15","author":"Hoffman","year":"1989","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib86","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/mrdd.1028","article-title":"Infectious and immune factors in the pathogenesis of neurodevelopmental disorders: epidemiology, hypotheses, and animal models","volume":"7","author":"Hornig","year":"2001","journal-title":"Ment. Retard Dev. Disabil. Res. Rev."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib87","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1001\/archgenpsychiatry.2008.514","article-title":"Elevated striatal dopamine function linked to prodromal signs of schizophrenia","volume":"66","author":"Howes","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib88","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1017\/S0033291708003279","article-title":"Interrelated neuropsychological and anatomical evidence of hippocampal pathology in the at-risk mental state","volume":"38","author":"Hurlemann","year":"2008","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib89","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0006-8993(79)90349-4","article-title":"Synaptic density in human frontal cortex \u2013 developmental changes and effects of aging","volume":"163","author":"Huttenlocher","year":"1979","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib90","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z","article-title":"Regional differences in synaptogenesis in human cerebral cortex","volume":"387","author":"Huttenlocher","year":"1997","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib91","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/archgenpsychiatry.2008.540","article-title":"Translating scientific opportunity into public health impact: a strategic plan for research on mental illness","volume":"66","author":"Insel","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib92","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0006-3223(98)00359-X","article-title":"Schizophrenia and the influenza epidemics of 1957 in Japan","volume":"46","author":"Izumoto","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib93","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/schbul\/sbp133","article-title":"Review of pathological hallmarks of schizophrenia: comparison of genetic models with patients and nongenetic models","volume":"36","author":"Jaaro-Peled","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib94","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev.med.58.060904.084114","article-title":"Schizophrenia: new pathological insights and therapies","volume":"58","author":"Jarskog","year":"2007","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib95","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neuroimage.2005.01.006","article-title":"Grey matter changes over time in high risk subjects developing schizophrenia","volume":"25","author":"Job","year":"2005","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib96","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1176\/appi.ajp.160.1.13","article-title":"Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia","volume":"160","author":"Kapur","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib97","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00406-009-0033-1","article-title":"Risperidone and haloperidol promote survival of stem cells in the rat hippocampus","volume":"260","author":"Keilhoff","year":"2010","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib98","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.schres.2010.03.036","article-title":"Progressive lateral ventricular enlargement in schizophrenia: a meta-analysis of longitudinal MRI studies","volume":"120","author":"Kempton","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib99","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0022-3956(99)00033-3","article-title":"Development, disease and degeneration in schizophrenia: a unitary pathophysiological model","volume":"33","author":"Keshavan","year":"1999","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib100","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1017\/S0954579499002199","article-title":"Brain maturational processes and delayed onset in schizophrenia","volume":"11","author":"Keshavan","year":"1999","journal-title":"Dev. Psychopathol."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib101","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/09540260701486233","article-title":"Are brain structural abnormalities useful as endophenotypes in schizophrenia?","volume":"19","author":"Keshavan","year":"2007","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib102","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0278-5846(99)00026-3","article-title":"New trends in developmental neuroimaging in psychiatry","volume":"23","author":"Keshavan","year":"1999","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib103","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1046\/j.0953-816X.2000.01320.x","article-title":"Differential DNA damage in response to the neonatal and adult excitotoxic hippocampal lesion in rats","volume":"12","author":"Khaing","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib104","first-page":"R1596","article-title":"Comparison of acute phase responses induced in rabbits by lipopolysaccharide and double-stranded RNA","volume":"267","author":"Kimura","year":"1994","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib105","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1001\/archpsyc.58.2.158","article-title":"Diagnosing schizophrenia in the initial prodromal phase","volume":"58","author":"Klosterkotter","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib106","doi-asserted-by":"crossref","first-page":"12176","DOI":"10.1523\/JNEUROSCI.3479-08.2008","article-title":"A\u00a0structural MRI study of human brain development from birth to 2 years","volume":"28","author":"Knickmeyer","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib107","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/cercor\/bhp166","article-title":"Maturational trajectories of cortical brain development through the pubertal transition: unique species and sex differences in the monkey revealed through structural magnetic resonance imaging","volume":"20","author":"Knickmeyer","year":"2010","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib108","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/sj.npp.1301233","article-title":"Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys","volume":"32","author":"Konopaske","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib109","series-title":"Dementia Praecox and Paraphrenia","author":"Kraepelin","year":"1919"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib110","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1001\/archpsyc.65.8.955","article-title":"Estrogen in severe mental illness: a potential new treatment approach","volume":"65","author":"Kulkarni","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib111","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1586\/ern.10.93","article-title":"Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disorders","volume":"10","author":"Larson","year":"2010","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib112","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0006-3223(99)00067-0","article-title":"Increased dopamine transmission in schizophrenia: relationship to illness phases","volume":"46","author":"Laruelle","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib113","doi-asserted-by":"crossref","first-page":"9235","DOI":"10.1073\/pnas.93.17.9235","article-title":"Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects","volume":"93","author":"Laruelle","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib114","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0149-7634(99)00032-9","article-title":"Psychobiological risk factors for vulnerability to psychostimulants in human adolescents and animal models","volume":"23","author":"Laviola","year":"1999","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib115","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/schbul\/sbm158","article-title":"Brain structure and function changes during the development of schizophrenia: the evidence from studies of subjects at increased genetic risk","volume":"34","author":"Lawrie","year":"2008","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib116","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0140-6736(98)06244-8","article-title":"Magnetic resonance imaging of brain in people at high risk of developing schizophrenia","volume":"353","author":"Lawrie","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib117","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1192\/bjp.181.2.138","article-title":"Temporal lobe volume changes in people at high risk of schizophrenia with psychotic symptoms","volume":"181","author":"Lawrie","year":"2002","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib118","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2165\/00023210-200519030-00002","article-title":"Prevention of schizophrenia: can it be achieved?","volume":"19","author":"Lee","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib119","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.neubiorev.2006.06.001","article-title":"Brain development in children and adolescents: insights from anatomical magnetic resonance imaging","volume":"30","author":"Lenroot","year":"2006","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib120","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bandc.2009.10.008","article-title":"Sex differences in the adolescent brain","volume":"72","author":"Lenroot","year":"2010","journal-title":"Brain Cogn."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib121","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.neuroimage.2007.03.053","article-title":"Sexual dimorphism of brain developmental trajectories during childhood and adolescence","volume":"36","author":"Lenroot","year":"2007","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib122","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/nm1478","article-title":"Pathophysiologically based treatment interventions in schizophrenia","volume":"12","author":"Lewis","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib123","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.neuro.25.112701.142754","article-title":"Schizophrenia as a disorder of neurodevelopment","volume":"25","author":"Lewis","year":"2002","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib124","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1007\/BF02245006","article-title":"Interaction of antipsychotic drugs with neurotransmitter receptor sites in\u00a0vitro and in\u00a0vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors","volume":"112","author":"Leysen","year":"1993","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib125","doi-asserted-by":"crossref","first-page":"e6354","DOI":"10.1371\/journal.pone.0006354","article-title":"Prenatal immune challenge is an environmental risk factor for brain and behavior change relevant to schizophrenia: evidence from MRI in a mouse model","volume":"4","author":"Li","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib126","doi-asserted-by":"crossref","first-page":"10218","DOI":"10.1073\/pnas.88.22.10218","article-title":"Synchronized overproduction of neurotransmitter receptors in diverse regions of the primate cerebral cortex","volume":"88","author":"Lidow","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib127","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0006-3223(01)01067-8","article-title":"Longitudinal study of brain morphology in first episode schizophrenia","volume":"49","author":"Lieberman","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib130","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0006-3223(01)01303-8","article-title":"The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches","volume":"50","author":"Lieberman","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib128","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1124\/pr.107.00107","article-title":"Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection","volume":"60","author":"Lieberman","year":"2008","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib129","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1176\/appi.ajp.157.11.1727","article-title":"Delayed detection of psychosis: causes, consequences, and effect on public health","volume":"157","author":"Lieberman","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib131","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/archpsyc.62.4.361","article-title":"Antipsychotic drug effects on brain morphology in first-episode psychosis","volume":"62","author":"Lieberman","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib132","first-page":"282","article-title":"Using animal models to test a neurodevelopmental hypothesis of schizophrenia","volume":"29","author":"Lipska","year":"2004","journal-title":"J.\u00a0Psychiatry Neurosci."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib133","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0893-133X(02)00282-8","article-title":"Neonatal damage of the ventral hippocampus impairs working memory in the rat","volume":"27","author":"Lipska","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib134","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/npp.1993.44","article-title":"Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia","volume":"9","author":"Lipska","year":"1993","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib135","doi-asserted-by":"crossref","first-page":"8906","DOI":"10.1073\/pnas.92.19.8906","article-title":"Genetic variation in vulnerability to the behavioral effects of neonatal hippocampal damage in rats","volume":"92","author":"Lipska","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib136","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0893-133X(00)00137-8","article-title":"To model a psychiatric disorder in animals: schizophrenia as a reality test","volume":"23","author":"Lipska","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib137","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.tins.2008.02.005","article-title":"Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia","volume":"31","author":"Lisman","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib138","doi-asserted-by":"crossref","first-page":"11424","DOI":"10.1523\/JNEUROSCI.2847-07.2007","article-title":"Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia","volume":"27","author":"Lodge","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib139","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF03033801","article-title":"Hippocampal dysfunction and disruption of dopamine system regulation in an animal model of schizophrenia","volume":"14","author":"Lodge","year":"2008","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib140","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bbr.2009.01.031","article-title":"Gestational methylazoxymethanol acetate administration: a developmental disruption model of schizophrenia","volume":"204","author":"Lodge","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib141","article-title":"Developmental pathology, dopamine, stress and schizophrenia","author":"Lodge","year":"2010","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib142","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1111\/j.1460-9568.2006.05175.x","article-title":"Longitudinal magnetic resonance imaging study of rhesus monkey brain development","volume":"24","author":"Malkova","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib143","article-title":"Critical age windows for neurodevelopmental psychiatric disorders: evidence from animal models","author":"Marco","year":"2010","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib144","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0006-3223(01)01209-4","article-title":"Cytokine effects on cortical neuron MAP-2 immunoreactivity: implications for schizophrenia","volume":"50","author":"Marx","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib145","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.4088\/JCP.v64n0909","article-title":"A\u00a03-year naturalistic study of 53\u00a0p.eschool children with pervasive developmental disorders treated with risperidone","volume":"64","author":"Masi","year":"2003","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib146","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/dev.20381","article-title":"Changes in hyporesponsiveness to acute amphetamine and age differences in tyrosine hydroxylase immunoreactivity in the brain over adolescence in male and female rats","volume":"51","author":"Mathews","year":"2009","journal-title":"Dev. Psychobiol."},{"issue":"Suppl. 6","key":"10.1016\/j.neuropharm.2011.04.019_bib147","first-page":"20","article-title":"Treatment challenges and safety considerations for antipsychotic use in children and adolescents with psychoses","volume":"65","author":"McConville","year":"2004","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib148","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.pnpbp.2009.09.019","article-title":"Adolescent development, hypothalamic-pituitary-adrenal function, and programming of adult learning and memory","volume":"34","author":"McCormick","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib149","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0006-3223(99)00084-0","article-title":"Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course?","volume":"46","author":"McGlashan","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib150","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/schbul\/sbl032","article-title":"Is active psychosis neurotoxic?","volume":"32","author":"McGlashan","year":"2006","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib151","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/schbul\/19.1.71","article-title":"Subtype progression and pathophysiologic deterioration in early schizophrenia","volume":"19","author":"McGlashan","year":"1993","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib152","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/archpsyc.57.7.637","article-title":"Schizophrenia as a disorder of developmentally reduced synaptic connectivity","volume":"57","author":"McGlashan","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib153","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/schbul\/22.2.201","article-title":"Early detection and intervention with schizophrenia: rationale","volume":"22","author":"McGlashan","year":"1996","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib154","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/oxfordjournals.schbul.a006896","article-title":"Pre-onset detection and intervention research in schizophrenia psychoses: current estimates of benefit and risk","volume":"27","author":"McGlashan","year":"2001","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib155","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1176\/ajp.2006.163.5.790","article-title":"Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis","volume":"163","author":"McGlashan","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib156","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/j.2051-5545.2008.tb00182.x","article-title":"Early intervention in psychosis: concepts, evidence and future directions","volume":"7","author":"McGorry","year":"2008","journal-title":"World Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib157","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/archpsyc.59.10.921","article-title":"Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms","volume":"59","author":"McGorry","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib158","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/schbul\/20.2.263","article-title":"Prenatal influenza infections and adult schizophrenia","volume":"20","author":"Mednick","year":"1994","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib159","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00213-009-1504-9","article-title":"Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia","volume":"206","author":"Meyer","year":"2009","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib160","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.pneurobio.2009.10.018","article-title":"Epidemiology-driven neurodevelopmental animal models of schizophrenia","volume":"90","author":"Meyer","year":"2010","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib161","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.neubiorev.2009.05.001","article-title":"In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders","volume":"33","author":"Meyer","year":"2009","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib162","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.neubiorev.2004.10.012","article-title":"Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia","volume":"29","author":"Meyer","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib163","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.bbi.2005.11.003","article-title":"Immunological stress at the maternal-foetal interface: a link between neurodevelopment and adult psychopathology","volume":"20","author":"Meyer","year":"2006","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib164","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1523\/JNEUROSCI.0099-06.2006","article-title":"The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology","volume":"26","author":"Meyer","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib165","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbi.2007.09.012","article-title":"Adult brain and behavioral pathological markers of prenatal immune challenge during early\/middle and late fetal development in mice","volume":"22","author":"Meyer","year":"2008","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib166","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00221-006-0419-5","article-title":"Prenatal and postnatal maternal contributions in the infection model of schizophrenia","volume":"173","author":"Meyer","year":"2006","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib167","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/schbul\/sbn131","article-title":"Evaluating early preventive antipsychotic and antidepressant drug treatment in an infection-based neurodevelopmental mouse model of schizophrenia","volume":"36","author":"Meyer","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib168","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/1073858406296401","article-title":"The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse?","volume":"13","author":"Meyer","year":"2007","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib169","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.neuro.28.051804.101459","article-title":"Adult neurogenesis in the mammalian central nervous system","volume":"28","author":"Ming","year":"2005","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib170","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.biopsych.2010.01.021","article-title":"Markers of basal ganglia dysfunction and conversion to psychosis: neurocognitive deficits and dyskinesias in the prodromal period","volume":"68","author":"Mittal","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib171","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/syn.20220","article-title":"Repeated antipsychotic drug exposure in developing rats: dopamine receptor effects","volume":"59","author":"Moran-Gates","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib172","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.euroneuro.2006.10.004","article-title":"Effects of risperidone on dopamine receptor subtypes in developing rat brain","volume":"17","author":"Moran-Gates","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib173","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0022-3956(92)90029-N","article-title":"Genes, viruses and neurodevelopmental schizophrenia","volume":"26","author":"Murray","year":"1992","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib174","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/bmj.295.6600.681","article-title":"Is schizophrenia a neurodevelopmental disorder?","volume":"295","author":"Murray","year":"1987","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib175","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/sj.mp.4000730","article-title":"Cytokine and growth factor involvement in schizophrenia\u2013support for the developmental model","volume":"5","author":"Nawa","year":"2000","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib176","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2165\/00023210-200721090-00002","article-title":"Neurogenic actions of atypical antipsychotic drugs and therapeutic implications","volume":"21","author":"Newton","year":"2007","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib177","first-page":"1026","article-title":"Psychosis in a child, associated with amphetamine administration","volume":"97","author":"Ney","year":"1967","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib178","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/nbm.1142","article-title":"MR technology for biological studies in mice","volume":"20","author":"Nieman","year":"2007","journal-title":"NMR Biomed."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib179","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.neuron.2010.01.019","article-title":"Knockdown of DISC1 by in utero gene transfer disturbs postnatal dopaminergic maturation in the frontal cortex and leads to adult behavioral deficits","volume":"65","author":"Niwa","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib180","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neuroscience.2006.07.029","article-title":"Maternal immune activation during pregnancy increases limbic GABAA receptor immunoreactivity in the adult offspring: implications for schizophrenia","volume":"143","author":"Nyffeler","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib181","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1192\/bjp.165.3.353","article-title":"The relationship of schizophrenic births to 16 infectious diseases","volume":"165","author":"O\u2019Callaghan","year":"1994","journal-title":"Br. J.\u00a0Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib182","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0022-3956(99)00029-1","article-title":"NMDA receptor hypofunction model of schizophrenia","volume":"33","author":"Olney","year":"1999","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib183","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.biopsych.2005.07.031","article-title":"Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia","volume":"59","author":"Ozawa","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib184","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.schres.2007.05.002","article-title":"A\u00a0longitudinal study on the effects of typical versus atypical antipsychotic drugs on hippocampal volume in schizophrenia","volume":"94","author":"Panenka","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib185","doi-asserted-by":"crossref","first-page":"440","DOI":"10.47102\/annals-acadmedsg.V38N5p440","article-title":"Imaging in schizophrenia: looking back and peering ahead","volume":"38","author":"Pantelis","year":"2009","journal-title":"Ann. Acad. Med. Singapore"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib186","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11065-009-9114-1","article-title":"Neurobiological markers of illness onset in psychosis and schizophrenia: the search for a moving target","volume":"19","author":"Pantelis","year":"2009","journal-title":"Neuropsychol. Rev."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib187","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1046\/j.1440-1614.2003.01193.x","article-title":"Early and late neurodevelopmental disturbances in schizophrenia and their functional consequences","volume":"37","author":"Pantelis","year":"2003","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib188","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/schbul\/sbi034","article-title":"Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia","volume":"31","author":"Pantelis","year":"2005","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib189","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1126\/science.1150196","article-title":"Neuroscience. Maternal effects on schizophrenia risk","volume":"318","author":"Patterson","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib190","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbr.2008.12.016","article-title":"Immune involvement in schizophrenia and autism: etiology, pathology and animal models","volume":"204","author":"Patterson","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib191","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.tics.2004.12.008","article-title":"Mapping brain maturation and cognitive development during adolescence","volume":"9","author":"Paus","year":"2005","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib192","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/sj.mp.4000956","article-title":"Schizophrenia and viral infection during neurodevelopment: a focus on mechanisms","volume":"6","author":"Pearce","year":"2001","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib193","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/archneur.1994.00540210046012","article-title":"A\u00a0quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood","volume":"51","author":"Pfefferbaum","year":"1994","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib194","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1080\/00048670903107625","article-title":"Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: study design and baseline characteristics","volume":"43","author":"Phillips","year":"2009","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib195","article-title":"Risperidone Administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia","author":"Piontkewitz","year":"2010","journal-title":"Schizophr. Bull"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib196","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.biopsych.2009.07.005","article-title":"Clozapine administration in adolescence prevents postpubertal emergence of brain structural pathology in an animal model of schizophrenia","volume":"66","author":"Piontkewitz","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib267","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2011.06.007","article-title":"Abnormal trajectories of neurodevelopment and behavior following in-utero insult in the rat","author":"Piontkewitz","year":"2011","journal-title":"Biol. Psych"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib197","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0165-3806(99)00168-6","article-title":"Effects of neonatal rat Borna disease virus (BDV) infection on the postnatal development of the brain monoaminergic systems","volume":"119","author":"Pletnikov","year":"2000","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib198","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1172\/JCI32483","article-title":"Antipsychotics in the treatment of autism","volume":"118","author":"Posey","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib199","series-title":"Behavioral Neurobiology of Schizophrenia and its Treatment","first-page":"435","article-title":"Models of neurodevelopmental abnormalities in schizophrenia","author":"Powell","year":"2010"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib200","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1196\/annals.1386.035","article-title":"Estrogen action in neuroprotection and brain inflammation","volume":"1089","author":"Pozzi","year":"2006","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib201","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/schbul\/sbn017","article-title":"Structural cerebral variations as useful endophenotypes in schizophrenia: do they help construct \u201cextended endophenotypes\u201d?","volume":"34","author":"Prasad","year":"2008","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib202","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/sj.mp.4001642","article-title":"The neurodevelopmental model of schizophrenia: update 2005","volume":"10","author":"Rapoport","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib203","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J."},{"issue":"Pt 5","key":"10.1016\/j.neuropharm.2011.04.019_bib204","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/brain\/119.5.1763","article-title":"Brain development, gender and IQ in children. A volumetric imaging study","volume":"119","author":"Reiss","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib206","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/sj.npp.1300791","article-title":"Risperidone pretreatment prevents elevated locomotor activity following neonatal hippocampal lesions","volume":"31","author":"Richtand","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib207","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/schbul\/16.3.391","article-title":"The case of frontostriatal dysfunction in schizophrenia","volume":"16","author":"Robbins","year":"1990","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib208","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/schbul\/sbi044","article-title":"Synthesizing schizophrenia: a bottom-up, symptomatic approach","volume":"31","author":"Robbins","year":"2005","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib209","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/mp.2008.44","article-title":"Ontogeny of sensorimotor gating and immune impairment induced by prenatal immune challenge in rats: implications for the etiopathology of schizophrenia","volume":"15","author":"Romero","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib210","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/cne.903580306","article-title":"Postnatal maturation of the dopaminergic innervation of monkey prefrontal and motor cortices: a tyrosine hydroxylase immunohistochemical analysis","volume":"358","author":"Rosenberg","year":"1995","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eurpsy.2004.11.001","article-title":"Pharmacological intervention in the initial prodromal phase of psychosis","volume":"20","author":"Ruhrmann","year":"2005","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib212","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/08039480801984008","article-title":"Early detection and intervention of psychosis. A review","volume":"62","author":"Salokangas","year":"2008","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib213","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","article-title":"Risperidone compared with new and reference antipsychotic drugs: in\u00a0vitro and in\u00a0vivo receptor binding","volume":"124","author":"Schotte","year":"1996","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib214","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/schbul\/16.2.185","article-title":"The role of estrogens in schizophrenia gender differences","volume":"16","author":"Seeman","year":"1990","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib215","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1001\/archgenpsychiatry.2010.66","article-title":"Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis","volume":"67","author":"Seidman","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib216","doi-asserted-by":"crossref","first-page":"e634","DOI":"10.1542\/peds.2003-0264-F","article-title":"Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders","volume":"114","author":"Shea","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib217","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(01)00163-3","article-title":"A\u00a0review of MRI findings in schizophrenia","volume":"49","author":"Shenton","year":"2001","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib218","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1523\/JNEUROSCI.23-01-00297.2003","article-title":"Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring","volume":"23","author":"Shi","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib219","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.yfrne.2005.10.003","article-title":"Pubertal hormones organize the adolescent brain and behavior","volume":"26","author":"Sisk","year":"2005","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib220","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2010.01.016","article-title":"Neuroimaging predictors of transition to psychosis \u2013 a systematic review and meta-analysis","author":"Smieskova","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib221","doi-asserted-by":"crossref","first-page":"10695","DOI":"10.1523\/JNEUROSCI.2178-07.2007","article-title":"Maternal immune activation alters fetal brain development through interleukin-6","volume":"27","author":"Smith","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib222","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/jlb.62.3.369","article-title":"Polyribonucleotides induce nitric oxide production by human monocyte-derived macrophages","volume":"62","author":"Snell","year":"1997","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib223","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0074-7742(04)59006-2","article-title":"Serotonin and brain development","volume":"59","author":"Sodhi","year":"2004","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib224","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nn1008","article-title":"Mapping cortical change across the human life span","volume":"6","author":"Sowell","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib225","doi-asserted-by":"crossref","first-page":"8223","DOI":"10.1523\/JNEUROSCI.1798-04.2004","article-title":"Longitudinal mapping of cortical thickness and brain growth in normal children","volume":"24","author":"Sowell","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib226","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0149-7634(00)00014-2","article-title":"The adolescent brain and age-related behavioral manifestations","volume":"24","author":"Spear","year":"2000","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib227","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2010.05.034","article-title":"Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosis","author":"Stone","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib228","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/cercor\/bhh121","article-title":"Male-specific volume expansion of the human hippocampus during adolescence","volume":"15","author":"Suzuki","year":"2005","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib229","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0165-3806(95)00109-Q","article-title":"Evidence for dopamine receptor pruning between adolescence and adulthood in striatum but not nucleus accumbens","volume":"89","author":"Teicher","year":"1995","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib230","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/35004593","article-title":"Growth patterns in the developing brain detected by using continuum mechanical tensor maps","volume":"404","author":"Thompson","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib231","doi-asserted-by":"crossref","first-page":"11650","DOI":"10.1073\/pnas.201243998","article-title":"Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia","volume":"98","author":"Thompson","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib232","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.tins.2006.01.007","article-title":"Mapping brain maturation","volume":"29","author":"Toga","year":"2006","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib233","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neures.2004.05.010","article-title":"Perinatal inflammatory cytokine challenge results in distinct neurobehavioral alterations in rats: implication in psychiatric disorders of developmental origin","volume":"50","author":"Tohmi","year":"2004","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib234","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.devbrainres.2004.08.011","article-title":"Ventricular size mapping in a transgenic model of schizophrenia","volume":"154","author":"Torres","year":"2005","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib235","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0920-9964(88)90043-6","article-title":"Schizophrenic births and viral diseases in two states","volume":"1","author":"Torrey","year":"1988","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib236","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bbr.2008.11.039","article-title":"The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia","volume":"204","author":"Tseng","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib237","doi-asserted-by":"crossref","first-page":"12691","DOI":"10.1523\/JNEUROSCI.4166-08.2008","article-title":"A\u00a0neonatal ventral hippocampal lesion causes functional deficits in adult prefrontal cortical interneurons","volume":"28","author":"Tseng","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib238","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00213-006-0439-7","article-title":"Dopaminergic modulation of striatal plateau depolarizations in corticostriatal organotypic cocultures","volume":"191","author":"Tseng","year":"2007","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib239","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0920-9964(00)00032-3","article-title":"Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain","volume":"47","author":"Urakubo","year":"2001","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib240","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.eurpsy.2007.10.013","article-title":"Schizophrenia as a progressive brain disease","volume":"23","author":"van Haren","year":"2008","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib241","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/09540260701486332","article-title":"The effects of antipsychotic treatment on cerebral structure and function in schizophrenia","volume":"19","author":"Vita","year":"2007","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib242","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1523\/JNEUROSCI.5408-09.2010","article-title":"A\u00a0longitudinal examination of the neurodevelopmental impact of prenatal immune activation in mice reveals primary defects in dopaminergic development relevant to schizophrenia","volume":"30","author":"Vuillermot","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib243","doi-asserted-by":"crossref","first-page":"s52","DOI":"10.1192\/bjp.191.50.s52","article-title":"Neuroimaging and other neurobiological indices in schizophrenia: relationship to measurement of functional outcome","volume":"50","author":"Waddington","year":"2007","journal-title":"Br. J.\u00a0Psychiatry Suppl."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib244","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/jnr.10281","article-title":"Atypical neuroleptics stimulate neurogenesis in adult rat brain","volume":"69","author":"Wakade","year":"2002","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib245","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0920-9964(01)00347-4","article-title":"Pubertal neurodevelopment and the emergence of psychotic symptoms","volume":"54","author":"Walker","year":"2002","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib246","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/archpsyc.1987.01800190080012","article-title":"Implications of normal brain development for the pathogenesis of schizophrenia","volume":"44","author":"Weinberger","year":"1987","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib247","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0920-9964(95)00013-C","article-title":"Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground","volume":"16","author":"Weinberger","year":"1995","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib248","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archpsyc.59.6.553","article-title":"Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain?","volume":"59","author":"Weinberger","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib249","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00213-002-1313-x","article-title":"The \u201ctwo-headed\u201d latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment","volume":"169","author":"Weiner","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib250","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bbr.2009.05.004","article-title":"Using the pharmacology of latent inhibition to model domains of pathology in schizophrenia and their treatment","volume":"204","author":"Weiner","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib251","series-title":"Handbook of Experimental Pharmacology: Dopamine in the CNS","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/978-3-662-06765-9_13","article-title":"Dopamine in schizophrenia: Dysfunctional information processing in basal ganglia-thalamocortical split circuits","author":"Weiner","year":"2002"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib252","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.brainresbull.2004.08.006","article-title":"Chronic stress and social housing differentially affect neurogenesis in male and female rats","volume":"64","author":"Westenbroek","year":"2004","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib253","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/09540260701496869","article-title":"The neurobiological underpinnings of risk and conversion in relatives of patients with schizophrenia","volume":"19","author":"Whalley","year":"2007","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib254","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0196-9781(00)00327-2","article-title":"Isolation-rearing of rats produces deficits as adults in the serotonergic innervation of hippocampus","volume":"21","author":"Whitaker-Azmitia","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib255","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0361-9230(01)00615-3","article-title":"Serotonin and brain development: role in human developmental diseases","volume":"56","author":"Whitaker-Azmitia","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib256","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1017\/S1461145708009206","article-title":"Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia","volume":"12","author":"Winter","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib257","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.euroneuro.2008.06.001","article-title":"Dopamine and serotonin levels following prenatal viral infection in mouse\u2013implications for psychiatric disorders such as schizophrenia and autism","volume":"18","author":"Winter","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib258","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1503\/jpn.090013","article-title":"Hippocampal subdivision and amygdalar volumes in patients in an at-risk mental state for schizophrenia","volume":"35","author":"Witthaus","year":"2010","journal-title":"J.\u00a0Psychiatry Neurosci."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib259","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0165-3806(97)00050-3","article-title":"Behavioral changes in rats with early ventral hippocampal damage vary with age at damage","volume":"101","author":"Wood","year":"1997","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib260","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1017\/S1121189X00003390","article-title":"The transition to psychosis: risk factors and brain changes","volume":"13","author":"Wood","year":"2004","journal-title":"Epidemiol. Psichiatr. Soc."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib261","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1176\/ajp.155.12.1661","article-title":"Is schizophrenia a progressive neurodevelopmental disorder?\u00a0Toward a unitary pathogenetic mechanism","volume":"155","author":"Woods","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib262","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/schbul\/22.2.283","article-title":"Monitoring and care of young people at incipient risk of psychosis","volume":"22","author":"Yung","year":"1996","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib263","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2010.02.869","article-title":"Progressive structural brain changes during development of psychosis","author":"Ziermans","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.04.019_bib264","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1038\/sj.npp.1300248","article-title":"Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia","volume":"28","author":"Zuckerman","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib265","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00213-003-1460-8","article-title":"Latent inhibition in 35-day-old rats is not an \u201cadult\u201d latent inhibition: implications for neurodevelopmental models of schizophrenia","volume":"169","author":"Zuckerman","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2011.04.019_bib266","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jpsychires.2004.08.008","article-title":"Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring","volume":"39","author":"Zuckerman","year":"2005","journal-title":"J.\u00a0Psychiatr. Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081100164X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081100164X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T18:59:23Z","timestamp":1741287563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839081100164X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":266,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S002839081100164X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2011.04.019","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}